Syntaris is a nasal spray medication primarily used for the treatment of allergic rhinitis, a condition characterized by symptoms such as sneezing, itching, nasal congestion, and runny nose due to allergies. The active ingredient in Syntaris is flunisolide, which belongs to a class of drugs known as corticosteroids. Corticosteroids work by reducing inflammation and suppressing the immune system's response to allergens, thereby alleviating the symptoms associated with allergic reactions. Syntaris is designed for intranasal use and is typically prescribed for both seasonal and perennial allergic rhinitis. It is important for patients to follow their healthcare provider's instructions regarding dosage and use to ensure effectiveness and minimize potential side effects.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.